115 related articles for article (PubMed ID: 7704510)
1. Antigens, receptors and dominant oncogenes and the prognosis of non-small cell lung cancer.
Stahel RA
Lung Cancer; 1994 Nov; 11 Suppl 3():S31-8. PubMed ID: 7704510
[No Abstract] [Full Text] [Related]
2. [Markers in lung cancer].
Balibrea JL
An R Acad Nac Med (Madr); 1993; 110(4):585-603; discussion 604-5. PubMed ID: 8048751
[No Abstract] [Full Text] [Related]
3. Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis.
Hilbe W; Dirnhofer S; Oberwasserlechner F; Eisterer W; Ammann K; Schmid T; Hilbe G; Thaler J; Wöll E
J Clin Pathol; 2003 Oct; 56(10):736-41. PubMed ID: 14514775
[TBL] [Abstract][Full Text] [Related]
4. DNA analysis by flow cytometry in nonsmall cell lung cancer: relationship to epidermal growth factor receptor, histology, tumour stage and survival.
Dazzi H; Thatcher N; Hasleton PS; Swindell R
Respir Med; 1990 May; 84(3):217-23. PubMed ID: 2171051
[TBL] [Abstract][Full Text] [Related]
5. The 5'-flanking region of human CD24 gene has cell-type-specific promoter activity in small-cell lung cancer.
Pass MK; Quintini G; Zarn JA; Zimmermann SM; Sigrist JA; Stahel RA
Int J Cancer; 1998 Nov; 78(4):496-502. PubMed ID: 9797140
[TBL] [Abstract][Full Text] [Related]
6. [Effects of a reduction or deviation of metastasis inhibitory factor MRP-1/CD9 on postoperative follow-up results in patients with lung cancer].
O S; Adachi S; Ieki Y; Nakano K; Higashiyama S; Kodama K; Tsuchii O; Taki T; Miyake M
Nihon Kyobu Geka Gakkai Zasshi; 1996 Mar; 44(3):321-3. PubMed ID: 8926405
[No Abstract] [Full Text] [Related]
7. Levels of complement regulatory molecules in lung cancer: disappearance of the D17 epitope of CD55 in small-cell carcinoma.
Sakuma T; Kodama K; Hara T; Eshita Y; Shibata N; Matsumoto M; Seya T; Mori Y
Jpn J Cancer Res; 1993 Jul; 84(7):753-9. PubMed ID: 7690355
[TBL] [Abstract][Full Text] [Related]
8. A novel molecular staging protocol for non-small cell lung cancer.
Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
[TBL] [Abstract][Full Text] [Related]
9. Mutations in K-ras codon 12 detected in plasma DNA are not an indicator of disease in patients with non-small cell lung cancer.
Trombino S; Neri M; Puntoni R; Angelini C; Loprevite M; Cesario A; Granone P; Imperatori A; Dominioni L; Ardizzoni A; Filiberti R; Russo P
Clin Chem; 2005 Jul; 51(7):1313-4. PubMed ID: 15976131
[No Abstract] [Full Text] [Related]
10. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].
Bréchot JM; Molina T; Theobald S; Depierre A; Lagrange JL; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Lemarié E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stcebner-Delbarre A;
Bull Cancer; 2002 Oct; 89(10):857-67. PubMed ID: 12441277
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of mutation in the epidermal growth factor receptor gene in Chinese patients with non-small cell lung cancer.
Jiang B; Zhu ZZ; Liu F; Hou LF; Gu J; Chen E; Tzeng CM; Zhu G
Clin Oncol (R Coll Radiol); 2006 Oct; 18(8):635. PubMed ID: 17051955
[No Abstract] [Full Text] [Related]
12. Coexpression of ganglioside antigen Fuc-GM1, neural-cell adhesion molecule, carcinoembryonic antigen, and carbohydrate tumor-associated antigen CA 50 in lung cancer.
Brezicka FT; Olling S; Bergman B; Berggren H; Engström CP; Hammarström S; Holmgren J; Larsson S; Lindholm L
Tumour Biol; 1992; 13(5-6):308-15. PubMed ID: 1337798
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of MCA, CA 19.9, CA 125 and TSA levels in lung cancer.
Yenisey C; Yenice S; Güner G; Güner S
Biochem Soc Trans; 1995 Nov; 23(4):530S. PubMed ID: 8654715
[No Abstract] [Full Text] [Related]
14. Greater enhancement of chemosensitivity by caffeine in high-p185neu-expressing human non-small-cell lung cancer cell lines.
Tsai CM; Perng RP; Chen MH; Jan YH; Hung MC; Ku TY; Chang KT
J Natl Cancer Inst; 1994 Jul; 86(13):1018-20. PubMed ID: 7911844
[No Abstract] [Full Text] [Related]
15. Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma.
Kibbelaar RE; Moolenaar KE; Michalides RJ; Van Bodegom PC; Vanderschueren RG; Wagenaar SS; Dingemans KP; Bitter-Suermann D; Dalesio O; Van Zandwijk N
Eur J Cancer; 1991; 27(4):431-5. PubMed ID: 1851619
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of PROM1 (CD133) confers poor prognosis in non-small cell lung cancer.
Qiu ZX; Zhao S; Mo XM; Li WM
Int J Clin Exp Pathol; 2015; 8(6):6589-95. PubMed ID: 26261540
[TBL] [Abstract][Full Text] [Related]
17. Molecular and biological factors in the prognosis of non-small cell lung cancer.
Kanters SD; Lammers JW; Voest EE
Eur Respir J; 1995 Aug; 8(8):1389-97. PubMed ID: 7489807
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine and epithelial markers in diagnostic bronchial lung cancer biopsy specimens.
Burnett HE; Zakhour HD; Walker C
Eur J Cancer; 1992; 28A(4-5):853-5. PubMed ID: 1381930
[TBL] [Abstract][Full Text] [Related]
19. Prognosis in small cell carcinoma of the lung--relationship to human milk fat globule 2 (HMFG2) antigen and other small cell associated antigens.
Allan SG; Hay FG; McIntyre MA; Leonard RC
Br J Cancer; 1987 Oct; 56(4):485-8. PubMed ID: 2825751
[TBL] [Abstract][Full Text] [Related]
20. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
